Table 3 Gender and age of the patients selected for MiRNAseq data analysis.

From: miRNA biomarkers for prognosis and therapy monitoring in a multi-ethnic cohort with SARS-CoV-2 infection

Patient groups

Gender (M/F)

Average Age

Control (n = 13)

10 M/3F (3:1)

47.62 ± 12.76

Infected (n = 38)

29 M/9F (3:1)

47.66 ± 12.92

  1. There was no significant difference in the average age of the two groups (p > 0.992).
Back to article page